95 related articles for article (PubMed ID: 26901496)
1. Hmga2 is dispensable for cutaneous squamous cell carcinoma.
White A; Flores A; Ong J; Lowry WE
Exp Dermatol; 2016 May; 25(5):409-12. PubMed ID: 26901496
[TBL] [Abstract][Full Text] [Related]
2. Biomarker function of HMGA2 in ultraviolet-induced skin cancer development.
Ha W; Hinde A; Xie L; Trager MH; Liu L
Exp Dermatol; 2020 Oct; 29(10):1021-1026. PubMed ID: 32780494
[TBL] [Abstract][Full Text] [Related]
3. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity.
Miyazawa J; Mitoro A; Kawashiri S; Chada KK; Imai K
Cancer Res; 2004 Mar; 64(6):2024-9. PubMed ID: 15026339
[TBL] [Abstract][Full Text] [Related]
4. HMGA2 is down-regulated by microRNA let-7 and associated with epithelial-mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs.
Liu Q; Liu T; Zheng S; Gao X; Lu M; Sheyhidin I; Lu X
Histopathology; 2014 Sep; 65(3):408-17. PubMed ID: 24612219
[TBL] [Abstract][Full Text] [Related]
5. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.
Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C
Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
9. The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites.
Günther K; Foraita R; Friemel J; Günther F; Bullerdiek J; Nimzyk R; Markowski DN; Behrens T; Ahrens W
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):197-205. PubMed ID: 27742669
[TBL] [Abstract][Full Text] [Related]
10. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
11. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
12. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.
Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
PLoS One; 2017; 12(10):e0185636. PubMed ID: 28968424
[TBL] [Abstract][Full Text] [Related]
13. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas.
Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y
Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458
[TBL] [Abstract][Full Text] [Related]
14. Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis.
Yamazaki H; Mori T; Yazawa M; Maeshima AM; Matsumoto F; Yoshimoto S; Ota Y; Kaneko A; Tsuda H; Kanai Y
Lab Invest; 2013 Dec; 93(12):1331-8. PubMed ID: 24145240
[TBL] [Abstract][Full Text] [Related]
15. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
16. Hmga2 translocation induced in skin tumorigenesis.
Li Y; Pi XY; Boland K; Lad S; Johnson K; Verfaillie C; Morris RJ
Oncotarget; 2017 May; 8(18):30019-30029. PubMed ID: 28415789
[TBL] [Abstract][Full Text] [Related]
17. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
18. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma.
Palumbo A; Da Costa NM; Esposito F; De Martino M; D'Angelo D; de Sousa VP; Martins I; Nasciutti LE; Fusco A; Ribeiro Pinto LF
Oncotarget; 2016 May; 7(18):25872-84. PubMed ID: 27027341
[TBL] [Abstract][Full Text] [Related]
20. HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
Li W; Wang Z; Zha L; Kong D; Liao G; Li H
Oncol Rep; 2017 Jan; 37(1):185-192. PubMed ID: 27878307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
